While DENTSPLY Sirona Inc has underperformed by -0.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -40.62%, with highs and lows ranging from $20.59 to $9.85, whereas the simple moving average fell by -21.18% in the last 200 days.
On November 07, 2025, William Blair Downgraded DENTSPLY Sirona Inc (NASDAQ: XRAY) to Mkt Perform. A report published by Morgan Stanley on April 15, 2025, Downgraded its rating to ‘Equal-Weight’ for XRAY. Wells Fargo Initiated an Equal Weight rating on February 14, 2025, and assigned a price target of $20. Jefferies January 23, 2025d its ‘Buy’ rating to ‘Hold’ for XRAY, as published in its report on January 23, 2025. Evercore ISI’s report from January 07, 2025 suggests a price prediction of $20 for XRAY shares, giving the stock a ‘In-line’ rating. Mizuho also rated the stock as ‘Neutral’.
Analysis of DENTSPLY Sirona Inc (XRAY)
It’s important to note that XRAY shareholders are currently getting $0.64 per share in dividends, so investors will receive a return regardless of how the company performs. Further, the quarter-over-quarter decrease in sales is -4.94%, showing a negative trend in the upcoming months.
DENTSPLY Sirona Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -44.44% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.99, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and XRAY is registering an average volume of 3.49M. On a monthly basis, the volatility of the stock is set at 3.32%, whereas on a weekly basis, it is put at 2.29%, with a loss of -0.18% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.73, showing growth from the present price of $11.27, which can serve as yet another indication of whether XRAY is worth investing in or should be passed over.
How Do You Analyze DENTSPLY Sirona Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.69%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 105.40% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
